Publications

cemka > Publications

Classer les publications sur l'année

  • Pharmaco-EpidĂ©miologie

    Predictors and burden of hospital readmission with recurrent Clostridioides difficile infection: a French nation-wide inception cohort study

    DINH A, LE MONNIER A, EMERY C, ALAMI S, TORRETON É, DUBURCQ A, BARBIER F.

    Eur J Clin Microbiol Infect Dis ; 2019;38(7):1297-1305

  • BiomĂ©trie et Analyses de bases de donnĂ©es/SNDS

    Migraine burden and costs in france: a nationwide claims database analysis of triptan users.

    DONNET A, EMERY C, ALY S, ALLAF B, CAYRE F, MAHIEU N, GOURMELEN J, LEVY P, FAGNANI F.

    J Med Econ ; 2019;22(7):616-624

  • BiomĂ©trie et Analyses de bases de donnĂ©es/SNDS

    Economic burden of chemotherapy-treated recurrent and/or metastatic squamous cell carcinoma of the head and neck in france: real world data from the permanent sample of national health insurance beneficiairies.

    LAFUMA A, COTTÉ FE, LE TOURNEAU C, EMERY C, GAUDIN AF, TORRETON E, GOURMELEN J, BONASTRE J.

    J Med Econ ; 2019;22(7):698-705

  • BiomĂ©trie et Analyses de bases de donnĂ©es/SNDS

    Factors associated with parathyroid hormone control in haemodialysis patients with secondary hyperparathyroidism treated with cinacalcet in real-world clinical practice : Mimosa study

    ROTTEMBOURG J, URENA-TORRES P, TOLEDANO D, GUEUTIN V, HAMANI A, COLDEFY O, HEBIBI H, GUINCESTRE T, EMERY C.

    Clinical Kidney Journal ; 2019;12(6):871-879

  • SantĂ© publique

    Remote Monitoring of Diabetes: A Cloud-Connected Digital System for Individuals With Diabetes and Their Health Care Providers.

    JOUBERT M, BENHAMOU PY, SCHAEPELYNCK P, HANAIRE H, CATARGI B, FARRET A, FONTAINE P, GUERCI B, REZNIK Y, NATHALIE JEANDIDIER N, PENFORNIS A, BOROT S, CHAILLOUS L, FRANC S, SERUSCLAT P, KHERBACHI Y, BAVIERE E, DETOURNAY B, SIMON P, CHARPENTIER G.

    J Diabetes Sci Technol ; 2019;13(6):1161-1168

  • Économie de la santĂ©

    Long-term cost-effectiveness of the fixed-dose combination of tiotropium plus olodaterol based on the DYNAGITO trial results.

    HOOGENDOORN M, CORRO RAMOS I, BALDWIN M, LUCIANI L, FABRON C, DETOURNAY B, PMH RUTTEN-VAN MÖLKEN M.

    Int J Chron Obstruct Pulmon Dis ; 2019;14:447-456

  • Économie de la santĂ©

    Cost-effectiveness of web-based patient-reported outcome surveillance in lung cancer patients.

    LIZÉE T, BASCH E, TRÉMOLIÈRES P, VOOG E, DOMONT J, PEYRAGA G, URBAN T, BENNOUNA J, SEPTANS A-L, BALAVOINE M, DETOURNAY B, DENIS F.

    J Thorac Oncol ; 2019;14(6):1012-1020

  • SantĂ© publique

    Early intervention for early psychosis in France, mapping of programs.

    MEUNIER-CUSSAC S, GOZLAN G, LECARDEUR L, DUBURCQ A, COUROUVE L

    Schizophrenia Bulletin ; 2018;44(S1):S125-S126

  • Autres

    Data sources, the data used, and the modality for collection

    MERCIER G, COSTA N, DUTOT C, RICHE VP, BAFFERT S, French costing group

    Rev Epidemiol Sante Publique ; 2018;66(S2):S73-S91

  • Économie de la santĂ©

    [Standard or specific unit costs: Which criteria for choosing an economic evaluation of health strategies in multicentric studies?]

    MARGIER J, BAFFERT S, LE CORROLLER-SORIANO AG, French Costing Group.

    Rev Epidemiol Sante Publique ; 2018;66(S2):S93-S99

  • SantĂ© publique

    Prise en charge précoce des premiers épisodes psychotiques en France : cartographie des programmes spécialisés en 2017

    GOZLAN G, MEUNIER-CUSSAC S,  LECARDEUR L, DUBURCQ A, COUROUVE L

    L’information psychiatrique ; 2018;94(5):393-401

  • SantĂ© publique

    Évaluation des coĂ»ts et des bĂ©nĂ©fices pour la santĂ© de la rĂ©novation Ă©nergĂ©tique en France

    EZRATTY V, ORMANDY D, LAURENT MH, BOUTIÈRE F, DUBURCQ A, COUROUVE L, CABANES PA.

    Environ Risque Santé ; 2018;17(4):401-410

  • Autres

    Parcours de soins, vers la mise en place d’un financement adaptĂ© : raisons et conditions de rĂ©ussite

    EMERY G, LE FUR C, EPIS-DE-FLEURIAN AA, JOSSERAN A, DETOURNAY B; les participants Ă  la table ronde “MĂ©dico-Ă©conomie” des Ateliers de Giens XXXIII

    Therapie ; 2018;73(1):25-32

  • BiomĂ©trie et Analyses de bases de donnĂ©es/SNDS

    An attempt at modeling COPD epidemiological trends in France

    BURGEL PR, LAURENDEAU C, RAHERISON C, FUHRMAN C, ROCHE N.

    Respir Res ; 2018;19(1):130

  • Économie de la santĂ©

    Determinants of return at work of breast cancer patients: results from the OPTISOINS01 French prospective study

    ARFI A, BAFFERT S, SOILLY AL, HUCHON C, REYAL F, ASSELAIN B, NEFFATI S, ROUZIER R, HÉQUET D.

    BMJ Open ; 2018;8(5):e020276